Download PDF
Laryngorhinootologie 2015; 94(03): 189-198
DOI: 10.1055/s-0034-1398672
CME Fortbildung
© Georg Thieme Verlag KG Stuttgart · New York

Erkrankungen des rheumatischen Formenkreis mit Manifestation im Larynx

Manifestation of Rheumatic Diseases in the Larynx
R. Reiter
1   Sektion für Phoniatrie und Pädaudiologie, Universitäts-Hals-Nasen-Ohrenklinik Ulm
,
S. Brosch
1   Sektion für Phoniatrie und Pädaudiologie, Universitäts-Hals-Nasen-Ohrenklinik Ulm
,
E. Smith
1   Sektion für Phoniatrie und Pädaudiologie, Universitäts-Hals-Nasen-Ohrenklinik Ulm
,
N. Froboese
2   Universitäts-Hals-Nasen-Ohrenklinik Ulm
,
T. F. Barth
3   Institut für Pathologie der Universitätsklinik Ulm
,
A. Pickhard
4   Hals-Nasen-Ohrenklinik der Technischen Universität München
› Author Affiliations
Further Information

Publication History

Publication Date:
09 March 2015 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Systemische Erkrankungen aus dem rheumatischen Formenkreis, wie eine rheumatoide Arthritis, eine Sarkoidose, ein Systemischer Lupus Erythematodes, eine Wegener Granulomatose und eine Relapsing Polychondritis können sich auch lokal im Larynx manifestieren. Da das klinische Erscheinungsbild häufig unspezifisch ist, wird die Diagnose oft erschwert bzw. deutlich verzögert gestellt. Differenzialdiagnostisch muss vor allem an Malignome gedacht werden, weshalb zur Diagnosesicherung häufig eine Probeexzision durchgeführt werden muss. Die Therapie solcher Erkrankungen erfolgt üblicherweise in enger Zusammenarbeit mit den Internisten bzw. den Rheumatologen.

Abstract

Rheumatic disorders (rheumatoid arthrits, sarcoidosis, systemic lupus erythematosus, Wegeners’s granulomatosis, relapsing polychondritis) may affect the larynx. The clinical symptoms are often unspecific, leading to delayed diagnosis. Malignant tumours should be considered in differential diagnosis with necessitating biopsy. Treatment may require interdisciplinary approach together with a specialist in internal medicine and rheumatology.

Schlüsselwörter

Larynx - Stimme - rheumatoide Arthritis - Sarkoidose - Systemischer Lupus Erythematodes

Key words

larynx - voice - rheumatoid arthritis - sarcoidosis - systemic lupus erythematosus
 

  • Literatur

  • 1 Smith E, Reiter R, Lindemann J, Brosch S. Dysphonie as a symptom of sarcoidosis. Laryngorhinootologie 2013; 92: 541-542
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Reiter R, Stier KH, Brosch S. Hoarseness in patient with systemic lupus erythematosus. Laryngorhinootologie 2011; 90: 226-227
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Murano E, Hosako-Naito Y, Tayama N, Oka T, Miyaji M, Kumada M, Niimi S. Bamboo node: primary vocal fold lesion as evidence of autoimmune disease. J Voice 2001; 15: 441-450
    CrossrefPubMedGoogle Scholar
  • 4 Hughes M, Hill J. Left vocal cord paralysis in systemic lupus erythematosus. Mod Rheumatol 2009; 19: 441-442
    CrossrefPubMedGoogle Scholar
  • 5 Peters JE, Salama AD, Ind PW. Wegener’s granulomatosis presenting as acute systemic vasculitis following 20 years of limited tracheobronchial disease. J Laryngol Otol 2009; 23: 1375-1377
    PubMedGoogle Scholar
  • 6 Mrówka-Kata K, Kata D, Lange D, Namysłowski G, Czecior E, Banert K. Sarcoidosis and its otolaryngological implications. Eur Arch Otorhinolaryngol 2010; 267: 1507-1514
    CrossrefPubMedGoogle Scholar
  • 7 Loehrl TA, Smith TL. Inflammatory and granulomatous lesions of the larynx and pharynx. Am J Med 2001; 3; 111 (Suppl 8A) 113S-117S
    PubMedGoogle Scholar
  • 8 Herold G. Innere Medizin. Köln: 2011: S1-S576
    Google Scholar
  • 9 Ramos HV, Pillon J, Kosugi EM, Fujita R, Pontes P. Laryngeal assessment in rheumatic disease patients. Braz J Otorhinolaryngol 2005; 71: 499-503 25
    PubMedGoogle Scholar
  • 10 Gottschlich S, Ambrosch P, Kramkowski D, Laudien M, Buchelt T, Gross WL, Hellmich B. Head and neck manifestations of Wegener’s granulomatosis. Rhinology 2006; 44: 227-233
    PubMedGoogle Scholar
  • 11 Knopf A, Bas M, Chaker A, Strassen U, Pickhard A, Stark T, Lahmer T, Thürmel K. Rheumatic disorders affecting the head and neck: underestimated diseases. Rheumatology (Oxford) 2011; 50: 2029-3426
    CrossrefPubMedGoogle Scholar
  • 12 Iacovou E, Vlastarakos PV, Nikolopoulos TP. Laryngeal Involvement in Connective Tissue Disorders. Is it Important for Patient Management? Indian J. Otolaryngol Head Neck Surg 2014; 66 (Suppl 1): 22-29
    PubMedGoogle Scholar
  • 13 Brooker DS. Rheumatoid arthritis: otorhinolaryngological manifestations. Clin Otolaryngol Allied Sci 1988; 13: 239-246
    CrossrefPubMedGoogle Scholar
  • 14 Voulgari PV, Papazisi D, Bai M, Zagorianakou P, Assimakopoulos D, Drosos AA. Laryngeal involvement in rheumatoid arthritis. Rheumatol Int 2005; 25: 321-325
    CrossrefPubMedGoogle Scholar
  • 15 Bayar N, Kara SA, Keleş I, Koç C, Altinok D, Orkun S. Cricoarytenoiditis in rheumatoid arthritis: radiologic and clinical study. J Otolaryngol 2003; 32: 373-378
    CrossrefPubMedGoogle Scholar
  • 16 Abdel-Aziz M, Azab NA, Bassyouni IH, Hamdy G. Laryngeal involvement in juvenile idiopathic arthritis patients. Clin Rheumatol 2011; 30: 1251-1256
    CrossrefPubMedGoogle Scholar
  • 17 Lawry GV, Finerman ML, Hanafee WN, Mancuso AA, Fan PT, Bluestone R. Laryngeal involvement in rheumatoid arthritis. A clinical, laryngoscopic and computerized tomographic study. Arthritis Rheum 1984; 27: 873-882
    CrossrefPubMedGoogle Scholar
  • 18 Speyer R, Speyer I, Heijnen MA. Prevalence and relative risk of dysphonia in rheumatoid arthritis. J Voice 2008; 22: 232-237
    CrossrefPubMedGoogle Scholar
  • 19 Kolman J, Morris I. Cricoarytenoid arthritis: a cause of acute upper airway obstruction in rheumatoid arthritis. Can J Anaesth 2002; 49: 729-732
    CrossrefPubMedGoogle Scholar
  • 20 Pathan EM, Oak JL, Jakareddy R, Sathe S, Kejriwal A. Upper airway obstruction due to cricoarytenoid arthritis in a case of systemic onset juvenile rheumatoid arthritis. J Assoc Physicians India 2001; 49: 566-567
    PubMedGoogle Scholar
  • 21 Kamanli A, Gok U, Sahin S, Kaygusuz I, Ardicoglu O, Yalcin S. Bilateral cricoarytenoid joint involvement in rheumatoid arthritis: a case report. Rheumatology (Oxford) 2001; 40: 593-594
    CrossrefPubMedGoogle Scholar
  • 22 Eckel HE, Wittekindt C, Klussmann JP, Schroeder U, Sittel C. Management of bilateral arytenoid cartilage fixation versus recurrent laryngeal nerve paralysis. Ann Otol Rhinol Laryngol 2003; 112: 103-108
    PubMedGoogle Scholar
  • 23 Sørensen WT, Møller-Andersen K, Behrendt N. Rheumatoid nodules of the larynx. J Laryngol Otol 1998; 112: 573-574
    PubMedGoogle Scholar
  • 24 Teitel AD, MacKenzie CR, Stern R, Paget SA. Laryngeal involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1992; 22: 203-214
    CrossrefPubMedGoogle Scholar
  • 25 Hilgert E, Toleti B, Kruger K, Nejedlo I. Hoarseness due to bamboo nodes in patients with autoimmune diseases: a review of literature. J Voice 2008; 22: 343-350
    CrossrefPubMedGoogle Scholar
  • 26 García MA, Alarcón GS, Boggio G, Hachuel L, Marcos AI, Marcos JC, Gentiletti S, Caeiro F, Sato EI, Borba EF, Brenol JC, Massardo L, Molina-Restrepo JF, Vásquez G, Guibert-Toledano M, Barile-Fabris L, Amigo MC, Huerta-Yáñez GF, Cucho-Venegas JM, Chacón-Diaz R, Pons-Estel BA. Primary cardiac disease in systemic lupus erythematosus patients: protective and risk factors – data from a multi-ethnic Latin American cohort. Rheumatology (Oxford) 2014; [Epub ahead of print]
    PubMedGoogle Scholar
  • 27 Schwemmle C, Kreipe HH, Witte T, Ptok M. Bamboo nodes associated with mixed connective tissue disease as a cause of hoarseness. Rheumatol Int 2013; 33: 777-781
    CrossrefPubMedGoogle Scholar
  • 28 Cannady SB, Batra PS, Koening C, Lorenz RR, Citardi MJ, Langford C, Hoffman GS. Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases. Laryngoscope 2009; 119: 757-761
    CrossrefPubMedGoogle Scholar
  • 29 Wittekindt C, Lüers JC, Drebber U, Guntinas-Lichius O, Hüttenbrink KB. ANCA-negative subglottic laryngeal stenosis in childhood. HNO 2007; 55: 807-811
    CrossrefPubMedGoogle Scholar
  • 30 Belostotsky VM, Shah V, Dillon MJ. Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol 2002; 17: 754-761
    CrossrefPubMedGoogle Scholar
  • 31 Blaivas AJ, Strauss W, Yudd M. Subglottic stenosis as a complication of Wegener’s granulomatosis. Prim Care Respir J 2008; 17: 114-116
    CrossrefPubMedGoogle Scholar
  • 32 Gluth MB, Shinners PA, Kasperbauer JL. Subglottic stenosis associated with Wegener’s granulomatosis. Laryngoscope 2003; 113: 1304-1307
    CrossrefPubMedGoogle Scholar
  • 33 Belloso A, Estrach C, Keith AO. Supraglottic stenosis in localized Wegener granulomatosis. Ear Nose Throat J 2008; 87: E11-E14
    PubMedGoogle Scholar
  • 34 Morgenthau AS, Teirstein AS. Sarcoidosis of the upper and lower airways. Expert Rev Respir Med 2011; 5: 823-833
    CrossrefPubMedGoogle Scholar
  • 35 Schwartzbauer HR, Tami TA. Ear, nose, and throat manifestations of sarcoidosis. Otolaryngol Clin North Am 2003; 36: 673-684
    CrossrefPubMedGoogle Scholar
  • 36 Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003; 29 : 1111-1118
    PubMedGoogle Scholar
  • 37 Dean CM, Sataloff RT, Hawkshaw MJ, Pribikin E. Laryngeal sarcoidosis. J Voice 2002; 16: 283-288
    CrossrefPubMedGoogle Scholar
  • 38 Gallivan GJ, Landis JN. Sarcoidosis of the larynx: preserving and restoring airway and professional voice. J Voice 1993; 7: 81-94
    CrossrefPubMedGoogle Scholar
  • 39 Bower JS, Belen JE, Weg JG, Dantzker DR. Manifestations and treatment of laryngeal sarcoidosis. Am Rev Respir Dis 1980; 122: 325-332
    PubMedGoogle Scholar
  • 40 Fortune S, Courey MS. Isolated laryngeal sarcoidosis. Otolaryngol Head Neck Surg 1998; 118: 868-870
    CrossrefPubMedGoogle Scholar
  • 41 James JC, Simpson CB. Treatment of laryngeal sarcoidosis with CO2 laser and mitomycin-C. Otolaryngol Head Neck Surg 2004; 130: 262-264
    CrossrefPubMedGoogle Scholar
  • 42 Neel 3rd HB, McDonald TJ. Laryngeal sarcoidosis: report of 13 patients. Ann Otol Rhinol Laryngol 1982; 91 (4 Pt 1): 359-362
    PubMedGoogle Scholar
  • 43 Davis C, Girzadas Jr DV. Laryngeal sarcoidosis causing acute upper airway obstruction. Am J Emerg Med 2008; 26: 114.e1-114.e3
    PubMedGoogle Scholar
  • 44 Yanardağ H, Enoz M, Papila I, Uygun S, Caner M, Karayel T. Upper respiratory tract involvement of sarcoidosis in the Turkish population. Otolaryngol Head Neck Surg 2006; 134: 848-851
    CrossrefPubMedGoogle Scholar
  • 45 Plaschke CC, Owen HH, Rasmussen N. Clinically isolated laryngeal sarcoidosis. Eur Arch Otorhinolaryngol 2011; 268: 575-804
    CrossrefPubMedGoogle Scholar
  • 46 Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med 1998; 129: 114-122
    CrossrefPubMedGoogle Scholar
  • 47 Puéchal X, Terrier B, Mouthon L, Costedoat-Chalumeau N, Guillevin L, Le Jeunne C. Relapsing polychondritis. Joint Bone Spine 2014; 81: 118-124
    CrossrefPubMedGoogle Scholar
  • 48 Kim CM, Kim BS, Cho KJ, Hong SJ. Laryngotracheal involvement of relapsing polychondritis in a Korean girl. Pediatr Pulmonol 2003; 35: 314-317
    CrossrefPubMedGoogle Scholar
  • 49 Woodbury K, Smith LJ. Relapsing polychondritis: a rare etiology of dysphonia and novel approach to treatment. Laryngoscope 2011; 121: 1006-1008
    CrossrefPubMedGoogle Scholar
  • 50 Karaiskaki N, Mann WJ. Subglottic tracheal stenosis. HNO 2012; 60: 505-510
    CrossrefPubMedGoogle Scholar
  • 51 Karaman E, Duman C, Cansz H, Ylmaz M, Ibrahimov M. Laryngotracheal reconstruction at relapsing polychondritis. J Craniofac Surg 2010; 21: 211-212
    CrossrefPubMedGoogle Scholar
  • 52 McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1976; 55: 193-215
    CrossrefPubMedGoogle Scholar
  • 53 Fan YC, Li WG, Zheng MH, Gao W, Zhang YY, Song LJ. Invasive fungal infection in patients with systemic lupus erythematosus: experience from a single institute of Northern China. Gene 2012; 10 : 184-187
    PubMedGoogle Scholar
  • 54 Bejar C, Basset-Seguin N, Faure F, Fieschi C, Frances C, Guenne C, Lebbe C, Peraldi MN, Roux J, Lamas G, Maubec E. SFORL workgroup . French ENT Society (SFORL) guidelines for the management of immunodeficient patients with head and neck cancer of cutaneous origin. Eur Ann Otorhinolaryngol Head Neck Dis 2014; 131: 121-129
    CrossrefPubMedGoogle Scholar
  • 55 Pickhard A, Smith E, Rottscholl R, Brosch S, Reiter R. Disorders of the larynx and chronic inflammatory diseases. Laryngorhinootologie 2012; 91: 758-756
    Article in Thieme ConnectPubMedGoogle Scholar